LPAR1 and cancer: Our laboratories and others reported that the LPA pathway stimulates breast [21, 45, 46] and ovarian [25, 34, 47] cancer metastasis, and LPAR1 antagonists significantly prevented lung, liver and bone metastasis formation [18, 48].